Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 245

1.

Clinical and neuropathological correlates of apolipoprotein E genotype in Alzheimer's disease. Window on molecular epidemiology.

Hyman BT, Gomez-Isla T, West H, Briggs M, Chung H, Growdon JH, Rebeck GW.

Ann N Y Acad Sci. 1996 Jan 17;777:158-65. Review.

PMID:
8624079
2.

Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease.

Gomez-Isla T, West HL, Rebeck GW, Harr SD, Growdon JH, Locascio JJ, Perls TT, Lipsitz LA, Hyman BT.

Ann Neurol. 1996 Jan;39(1):62-70.

PMID:
8572669
3.

Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease.

Nagy Z, Esiri MM, Jobst KA, Johnston C, Litchfield S, Sim E, Smith AD.

Neuroscience. 1995 Dec;69(3):757-61.

PMID:
8596645
4.

Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein.

Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A, Niinistö L, Halonen P, Kontula K.

N Engl J Med. 1995 Nov 9;333(19):1242-7.

5.
6.
7.

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA.

Science. 1993 Aug 13;261(5123):921-3.

PMID:
8346443
8.
9.

Dose-dependent association of apolipoprotein E allele epsilon 4 with late-onset, sporadic Alzheimer's disease.

Yoshizawa T, Yamakawa-Kobayashi K, Komatsuzaki Y, Arinami T, Oguni E, Mizusawa H, Shoji S, Hamaguchi H.

Ann Neurol. 1994 Oct;36(4):656-9.

PMID:
7944299
10.
11.

Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype.

Hyman BT, West HL, Rebeck GW, Lai F, Mann DM.

Arch Neurol. 1995 Apr;52(4):373-8.

PMID:
7710373
12.

Amyloid beta-protein, APOE genotype and head injury.

Nicoll JA, Roberts GW, Graham DI.

Ann N Y Acad Sci. 1996 Jan 17;777:271-5. Review.

PMID:
8624097
13.

Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease.

Hyman BT, Gomez-Isla T, Rebeck GW, Briggs M, Chung H, West HL, Greenberg S, Mui S, Nichols S, Wallace R, Growdon JH.

Ann N Y Acad Sci. 1996 Dec 16;802:1-5.

PMID:
8993478
14.

Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease.

Dal Forno G, Rasmusson DX, Brandt J, Carson KA, Brookmeyer R, Troncoso J, Kawas CH.

Arch Neurol. 1996 Apr;53(4):345-50.

PMID:
8929157
15.

Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias.

Morris CM, Massey HM, Benjamin R, Leake A, Broadbent C, Griffiths M, Lamb H, Brown A, Ince PG, Tyrer S, Thompson P, McKeith IG, Edwardson JA, Perry RH, Perry EK.

J Neural Transm Suppl. 1996;47:205-18.

PMID:
8841967
16.

Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions.

Ohm TG, Scharnagl H, März W, Bohl J.

Acta Neuropathol. 1999 Sep;98(3):273-80.

PMID:
10483785
17.

Apolipoprotein E genotype and neuropathological phenotype in two members of a German family with chromosome 14-linked early onset Alzheimer's disease.

Egensperger R, Kösel S, Schnabel R, Mehraein P, Graeber MB.

Acta Neuropathol. 1995;90(3):257-65.

PMID:
8525799
18.
19.

Evidence for apolipoprotein E epsilon 4 association in early-onset Alzheimer's patients with late-onset relatives.

Pérez-Tur J, Campion D, Martinez M, Brice A, Tardieu S, Hannequin D, Agid Y, Delacourte A, Clerget-Darpoux F, Chartier-Harlin MC.

Am J Med Genet. 1995 Dec 18;60(6):550-3.

PMID:
8825894
20.

Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.

Davidson Y, Gibbons L, Pritchard A, Hardicre J, Wren J, Tian J, Shi J, Stopford C, Julien C, Thompson J, Payton A, Thaker U, Hayes AJ, Iwatsubo T, Pickering-Brown SM, Pendleton N, Horan MA, Burns A, Purandare N, Lendon CL, Neary D, Snowden JS, Mann DM.

J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):515-7.

Supplemental Content

Support Center